All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
ABT real return snapshot: after CPI-U inflation, ABT returned −34.92% over the past year and −30.47% YTD, with dividends reinvested. Since Mar. 17, 1980, ABT is up +11,839.68% in real purchasing-power return, or +10.90%/yr, and is currently −42.92% below its real total-return high on Dec. 27, 2021.
Data ending Wed Jun. 10, 2026
| Mon 1980-03-17💬 to Wed 2026-06-10 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ABT × |
−30.47%
2026-06-10 |
−34.92%
2026-06-10 |
||||
| Abbott Laboratories NYSE Common Stock | ||||||
| Mon 1980-03-17💬 to Wed 2026-06-10 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABT × |
+11,839.68%
+10.90%/yr |
+10.93%/yr
(R2=0.954) |
||||
| Abbott Laboratories NYSE Common Stock | ||||||
| Mon 1980-03-17💬 to Wed 2026-06-10 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABT × |
$10,000.00
1980-03-17 |
$1,193,967.52
2026-06-10 |
||||
| Abbott Laboratories NYSE Common Stock | ||||||
| Year | ABT |
|---|---|
| 2026 (YTD) | −30.47% |
| 2025 | +9.93% |
| 2024 | +1.88% |
| 2023 | −1.05% |
| 2022 | −25.50% |
| 2021 | +21.95% |
| 2020 | +26.32% |
| 2019 | +19.35% |
| 2018 | +26.65% |
| 2017 | +48.88% |
| 2016 | −14.10% |
| 2015 | +1.13% |
| 2014 | +19.18% |
| 2013 | +22.12% |
| 2012 | +18.25% |
| 2011 | +18.26% |
| 2010 | −9.62% |
| 2009 | +1.80% |
| 2008 | −2.57% |
| 2007 | +13.40% |
| 2006 | +23.75% |
| 2005 | −16.35% |
| 2004 | +14.09% |
| 2003 | +17.07% |
| 2002 | −28.43% |
| 2001 | +15.29% |
| 2000 | +31.39% |
| 1999 | −26.76% |
| 1998 | +49.46% |
| 1997 | +29.76% |
| 1996 | +20.56% |
| 1995 | +27.21% |
| 1994 | +10.03% |
| 1993 | −2.66% |
| 1992 | −12.63% |
| 1991 | +51.46% |
| 1990 | +27.44% |
| 1989 | +38.29% |
| 1988 | −2.11% |
| 1987 | +3.48% |
| 1986 | +34.58% |
| 1985 | +62.03% |
| 1984 | −8.76% |
| 1983 | +14.95% |
| 1982 | +38.22% |
| 1981 | −12.26% |
| 1980 | +45.70% |
| Mon 1980-03-17💬 to Wed 2026-06-10 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABT × |
−42.92%
from 2021-12-27 peak |
−46.87%
2026-05-11 from 2021-12-27 peak |
||||
| Abbott Laboratories NYSE Common Stock | ||||||
| Period ending Wed 2026-06-10 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ABT × | −34.92% |
−19.15% −10.08%/yr |
−15.50% −5.46%/yr |
−28.42% −6.47%/yr |
+100.76% +7.22%/yr |
|
| Abbott Laboratories NYSE Common Stock | ||||||
